September, 2016 Somagenics will present recent progress in its RNA detection and sshRNA therapeutics programs in two posters at the OTS Annual Meeting in Montreal, Quebec, September 25-28, 2016.
Somagenics to present at the 7th non-coding RNA & RNAi Therapeutics conference, Boston, MA on September 14, 2016
Santa Cruz, Calif. September 14, 2016 Somagenics will present at the 7th non-coding RNA & RNAi Therapeutics conference by Global Technology Community on September 14 in Boston, MA. Dr. Johnston, CEO of Somagenics, will present progress in Somagenics’ Wound Healing program and briefly describe RealSeq®-AC, a novel method to prepare small RNA sequencing libraries with greatly reduced bias.
Rubicon Genomics Licenses Commercialization Rights from SomaGenics for Its RealSeq®-AC Technology for High-Throughput Sequencing of Small RNAs
Santa Cruz, Calif. July 28, 2016 SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for commercialization of SomaGenics’ RealSeq®-AC library preparation technology for sequencing small RNAs, including micro-RNAs and small fragments of large RNAs. Further terms of the agreement were not disclosed.
The RealSeq®-AC platform is a novel technology that dramatically reduces sequencing bias compared to standard methods for preparing libraries for small RNA sequencing. RealSeq®-AC allows detection and discovery of many small RNAs that are often underestimated by up to 104-fold of their true abundance.